Latest total revenue for BIOA: $13M, below the sector sector average of $1.3B.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2025
Trailing 12 months ending Dec 2025
As of the most recent data (December 2025), BIOA shows a total revenue of $13M. That compares with $13M in the prior-year period — up 4.2% year over year. That is below the sector sector average of $1.3B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BIOA's total revenue is now $13M (was $13M) — a 4.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BioAge Labs is outperforming or lagging.
The its sector sector average total revenue is about $1.3B. BioAge Labs is at $13M, which is lower that average. That is roughly 99.0% below the sector mean. Use the comparison chart on this page to see how BIOA stacks up against individual peers as well.
Tracking BIOA's total revenue over time shows whether BioAge Labs is scaling, shrinking, or reshaping that part of the business. The current reading is $13M That compares with $13M in the prior-year period — up 4.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total revenue page, Stockcircle has BioAge Labs's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $13M) with ownership activity and broader fundamentals.